Mylan NV (MYL)

19.14
NASDAQ : Health Technology
Prev Close 19.68
Day Low/High 19.11 / 19.78
52 Wk Low/High 16.63 / 32.23
Avg Volume 5.92M
Exchange NASDAQ
Shares Outstanding 516.13M
Market Cap 10.16B
EPS 0.70
P/E Ratio 209.00
Div & Yield N.A. (N.A)
Two Stocks Jumping off of Earnings

Two Stocks Jumping off of Earnings

And two reporting next week that look set to make a move. 

Mylan estimates, target boosted at BMO

More Weekly Triangles and Wedges

More Weekly Triangles and Wedges

Four stocks that have been trading in triangle or wedge patterns.

This Morning's Market Setup

Where it began. "As I mentioned earlier, the divergences seen since late summer are starting to weigh on stocks:  "Underperformance of the Russell Index. "Weakening in the cumulative advance/decline line of the Nasdaq. "Contraction in the number of ...

MYL Investor Mtg.

A Peculiar Mix of Action

A Peculiar Mix of Action

And a paucity of perky charts.

This Morning's Market Setup

Where it began. The rundown: U.S. futures are higher this morning (S&P up 6 handles, Nasdaq up 18 handles). European stocks are climbing, too (by about 0.8%). Nikkei is up 0.88%. Within the Nikkei, all major sub-groups finished in the green. Telecom...

The Next Deals Are in Hospital

The Next Deals Are in Hospital

A wave of M&A in the health sector makes sense.

Finding Good Picks Among 13Fs

Finding Good Picks Among 13Fs

I will explore Gannett because I love firms with many owned assets.

MYL Investor Mtg.

Mylan upgraded at Citi

Mylan estimates, target cut at Leerink

Mylan price target bumped at UBS

Mylan downgraded at Needham

An Intraday Snapshot

An Intraday Snapshot

10 big gainers that are still getable ... right now.

Mylan, Mondelez Remain Bargains

Mylan, Mondelez Remain Bargains

Stocks are still cheap despite "bubble" talk, especially Mondelez, Mylan, NFG and Plum Creek, says Russell Croft of the Croft Value Fund.

Mylan downgraded at Needham

Mylan upgraded at Morgan Stanley

MYL Investor Day

Mylan downgraded at Bernstein

Barclays Healthcare Conf.

Loving the Rally?

Loving the Rally?

Here is how I am picking apart the sectors looking for strong relative performance candidates.

Mylan was downgraded at Canaccord

A Healthy Investment Idea

The health sector is one the less-beaten-down areas amid market weakness.

Mylan upgraded at Leerink

Mylan upgraded at Canaccord

Boring Is Beautiful

Boring Is Beautiful

Here are two generic-drug companies that should hold up well, regardless of the current uncertainty.

It's Just Healthy Profit-Taking

It's Just Healthy Profit-Taking

There's no reason to read much into it.

Watch Mylan

Watch Mylan

The generic drugmaker may be preparing to break from a key short-term channel pattern.